Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Tests Accessioned in Natera's CLIA Laboratories by Quarter
Tests Accessioned in Natera's CLIA Laboratories (tests)
Natera Tests Accessioned in Natera's CLIA Laboratories: 1,030,100.00 tests in Q2 2026, up 22.7% from a year earlier. That is the highest of the 35 quarters on record here.
Where the Q2 2026 figure comes from
“Natera processed approximately 1,043,900 tests in the second quarter of 2026, including approximately 1,030,100 tests accessioned in its laboratory, compared to approximately 853,100 tests processed, including approximately 839,300 tests accessioned in its laboratory, in the second quarter of 2025”
Source: Form 8-K Ex 99.1 (2026-08-06) ↗
Tests accessioned directly in Natera's San Carlos, CA and Austin, TX CLIA-certified laboratories (excludes tests processed via the Constellation cloud software platform).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Tests Accessioned in Natera's CLIA Laboratories (tests) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,030,100.00 | +22.7% | Form 8-K Ex 99.1 (2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 999,200.00 | +18.8% | Form 10-Q (2026-03-31) ↗ |
| Q4 2025 | Dec 31, 2025 | 909,000.00 | +16.8% | Form 8-K Ex 99.1 (2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 879,700.00 | +15.6% | Form 8-K Ex 99.1 (2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 839,300.00 | +12.8% | Form 8-K Ex 99.1 (2026-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 840,800.00 | +17.0% | Form 10-Q (2026-03-31) ↗ |
| Q4 2024 | Dec 31, 2024 | 778,400.00 | +27.6% | Form 8-K Ex 99.1 (2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 760,700.00 | +24.7% | Form 8-K Ex 99.1 (2025-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 744,000.00 | +24.2% | Form 8-K Ex 99.1 (2025-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 718,700.00 | +18.3% | Form 10-Q (2025-03-31) ↗ |
| Q4 2023 | Dec 31, 2023 | 610,100.00 | +12.2% | Form 8-K Ex 99.1 (2025-02-27) ↗ |
| Q3 2023 | Sep 30, 2023 | 609,800.00 | – | Form 8-K Ex 99.1 (2024-11-12) ↗ |
| Q2 2023 | Jun 30, 2023 | 599,000.00 | +23.8% | Form 8-K Ex 99.1 (2024-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 607,700.00 | +28.4% | Form 10-Q (2024-03-31) ↗ |
| Q4 2022 | Dec 31, 2022 | 543,900.00 | +28.2% | Form 8-K Ex 99.1 (2024-02-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 484,000.00 | +33.9% | Form 8-K Ex 99.1 (2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | 473,200.00 | +41.9% | Form 10-Q (2023-03-31) ↗ |
| Q4 2021 | Dec 31, 2021 | 424,200.00 | +51.0% | Form 8-K Ex 99.1 (2023-02-28) ↗ |
| Q3 2021 | Sep 30, 2021 | 394,200.00 | +58.1% | Form 8-K Ex 99.1 (2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | 361,500.00 | +63.1% | Form 8-K Ex 99.1 (2022-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 333,400.00 | +49.9% | Form 10-Q (2022-03-31) ↗ |
| Q4 2020 | Dec 31, 2020 | 281,000.00 | +41.7% | Form 8-K Ex 99.1 (2022-02-24) ↗ |
| Q3 2020 | Sep 30, 2020 | 249,300.00 | +33.2% | Form 8-K Ex 99.1 (2021-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 221,600.00 | +21.9% | Form 8-K Ex 99.1 (2021-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 222,400.00 | +19.2% | Form 10-Q (2021-03-31) ↗ |
| Q4 2019 | Dec 31, 2019 | 198,300.00 | – | Form 8-K Ex 99.1 (2021-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | 187,200.00 | +19.5% | Form 10-Q (2019-09-30) ↗ |
| Q2 2019 | Jun 30, 2019 | 181,800.00 | +19.2% | Form 10-Q (2019-06-30) ↗ |
| Q1 2019 | Mar 31, 2019 | 186,500.00 | +21.2% | Form 10-Q (2020-03-31) ↗ |
| Q3 2018 | Sep 30, 2018 | 156,600.00 | +27.7% | Form 10-Q (2019-09-30) ↗ |
| Q2 2018 | Jun 30, 2018 | 152,500.00 | +28.5% | Form 10-Q (2019-06-30) ↗ |
| Q1 2018 | Mar 31, 2018 | 153,900.00 | +33.8% | Form 10-Q (2019-03-31) ↗ |
| Q3 2017 | Sep 30, 2017 | 122,600.00 | – | Form 10-Q (2018-09-30) ↗ |
| Q2 2017 | Jun 30, 2017 | 118,700.00 | – | Form 10-Q (2018-06-30) ↗ |
| Q1 2017 | Mar 31, 2017 | 115,000.00 | – | Form 10-Q (2018-03-31) ↗ |
Cite this data
StockData. (2026). Natera Tests Accessioned in Natera's CLIA Laboratories, quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/vol-tests-accessioned-lab
See every metric in the Natera KPI table. Data updated Nov 2, 2026.